CAS 1418033-25-6
:LMK-235
Description:
LMK-235, identified by its CAS number 1418033-25-6, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized as a selective inhibitor of certain protein kinases, which play crucial roles in various cellular processes, including cell growth, differentiation, and metabolism. The compound's structure typically features specific functional groups that contribute to its biological activity and selectivity. LMK-235 has been studied for its effects on cancer cell lines, demonstrating the ability to inhibit tumor growth by interfering with signaling pathways essential for cancer progression. Additionally, its pharmacokinetic properties, such as solubility and stability, are important for its efficacy as a drug candidate. Research continues to explore its full potential, including its mechanism of action and possible side effects, making it a subject of interest in ongoing pharmaceutical development.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
LMK-235
CAS:LMK-235 is a potent HDAC inhibitor, and is used in cancer research.Formula:C15H22N2O4Purity:98.18% - 99.68%Color and Shape:SolidMolecular weight:294.35LMK 235
CAS:Controlled Product<p>Applications LMK 235 is a histone deacetylase (HDAC)4 and HDAC5 inhibitor and has shown to have enhanced cytotoxic effects against the human cancer cell lines A2780, Cal27, Kyse510, and MDA-MB231.<br>References Marek, L., et. al.: J. Med. Chem., 56, 427 (2013)<br></p>Formula:C11H14BrNO·HClColor and Shape:NeatMolecular weight:292.6LMK 235
CAS:<p>Inhibitor of histone deacetylases 4 and 5</p>Formula:C15H22N2O4Purity:Min. 95%Molecular weight:294.35 g/mol
